未登录MSG-10: a Phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasis
Spec, Andrej; Pullman, John; Thompson, George R., III; Powderly, William G.; Tobin, Ellis H.; Vazquez, Jose; Wring, Stephen A.; Angulo, David; Helou, Silvia; Pappas, Peter G.; Ostrosky-Zeichner, Luis; Patterson, Thomas; Alexander, Barbara; Boucher, Helen; Pappas, Peter; Betts, Robert; Schuster, Mindy; Shoham, Shmuel; Revankar, Sanjay; Mushatt, David; Bedimo, Roger; Freifeld, Alison; Nguyen, Minh Hong; Mylonakis, Eleftherios; Kett, Daniel; Reboli, Annette; Walsh, Thomas; Pouch, Stephanie; Almyroudis, Nikolaos; Andes, David; Hadley, Susan; Barron, Michelle; Mullane, Katheen; Miller, Loren .png)
分享.png)
收藏分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
